JPMorgan Chase & Co’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6K | Buy |
8,997
+7,138
| +384% | +$11.6K | ﹤0.01% | 5385 |
|
|
2025
Q1 | $1.33K | Sell |
1,859
-8,808
| -83% | -$6.32K | ﹤0.01% | 5719 |
|
|
2024
Q4 | $11.8K | Sell |
10,667
-1,371
| -11% | -$1.52K | ﹤0.01% | 5320 |
|
|
2024
Q3 | $8.43K | Buy |
12,038
+11,055
| +1,125% | +$7.74K | ﹤0.01% | 5350 |
|
|
2024
Q2 | $983 | Sell |
983
-15,204
| -94% | -$15.2K | ﹤0.01% | 5600 |
|
|
2024
Q1 | $38.4K | Sell |
16,187
-8,311
| -34% | -$19.7K | ﹤0.01% | 5054 |
|
|
2023
Q4 | $55.1K | Sell |
24,498
-809
| -3% | -$1.82K | ﹤0.01% | 4981 |
|
|
2023
Q3 | $53.7K | Sell |
25,307
-5,603
| -18% | -$11.9K | ﹤0.01% | 4886 |
|
|
2023
Q2 | $95.5K | Sell |
30,910
-97,029
| -76% | -$300K | ﹤0.01% | 4651 |
|
|
2023
Q1 | $689K | Hold |
127,939
| – | – | ﹤0.01% | 3658 |
|
|
2022
Q4 | $851K | Sell |
127,939
-1,141
| -0.9% | -$7.59K | ﹤0.01% | 3456 |
|
|
2022
Q3 | $514K | Sell |
129,080
-42,297
| -25% | -$168K | ﹤0.01% | 3731 |
|
|
2022
Q2 | $852K | Sell |
171,377
-11,807
| -6% | -$58.7K | ﹤0.01% | 3583 |
|
|
2022
Q1 | $1.11M | Sell |
183,184
-20,779
| -10% | -$125K | ﹤0.01% | 3546 |
|
|
2021
Q4 | $2.37M | Sell |
203,963
-23,861
| -10% | -$277K | ﹤0.01% | 3121 |
|
|
2021
Q3 | $3.57M | Buy |
227,824
+217,202
| +2,045% | +$3.41M | ﹤0.01% | 2808 |
|
|
2021
Q2 | $199K | Sell |
10,622
-21,657
| -67% | -$406K | ﹤0.01% | 4504 |
|
|
2021
Q1 | $1.39M | Buy |
+32,279
| New | +$1.39M | ﹤0.01% | 3449 |
|